Kim Keck insider trades: Evolent Health (EVH) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Kim reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 7, 2025 | EVH | ↑ Buy | 10,540 | $9.44 | $99K | Direct | Mar 10, 2025 (3d) |
| Aug 10, 2020 | "OSH" | ↑ Buy | 5,000 | $21.00 | $105K | Direct | Sep 1, 2020 (22d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other EVH insiders
Open-market trades in the last 12 months
About Kim Keck's insider trades
Kim Keck is a director at Evolent Health (EVH). Since Aug 10, 2020, Kim has reported 2 open-market purchases worth $204K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (11 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EVH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.